Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» sofosbuvir/velpatasvir
sofosbuvir/velpatasvir
After The Deluge, Hep C Players Look For Opportunity
Seeking Alpha
Thu, 11/17/16 - 09:57 am
hepatitis C
Gilead Sciences
AbbVie
Epclusa
glecaprevir/pibrentasvir
sofosbuvir/velpatasvir
3 Potential Blockbuster Drugs Launching in 2016
Investors.com
Wed, 01/6/16 - 10:57 am
Merck
hepatitis C
elbasvir/grazoprevir
Gilead Sciences
sofosbuvir/velpatasvir
Eli Lilly
psoriasis
ixekizumab